Cita APA

Binder, C., Sellberg, F., Cvetkovski, F., Berglund, E., & Berglund, D. (2020). Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro. Front Immunol.

Chicago Style Citation

Binder, Christian, Felix Sellberg, Filip Cvetkovski, Erik Berglund, i David Berglund. "Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro." Front Immunol 2020.

Cita MLA

Binder, Christian, et al. "Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro." Front Immunol 2020.